SAMIMA KHATUN
Council of Scientific and Industrial Research, Jadavpur University, National Institute of Pharmaceutical Education and Research Department of Pharmaceutical Analysis, Dr. Hari Singh Gour University
0000-0002-3322-9915
About
Samima Khatun is a passionate medicinal chemist currently working as a Senior Research Fellow at the Department of Pharmaceutical Technology, Jadavpur University, Kolkata. She earned her M.S.(Pharm.) in Medicinal Chemistry from NIPER, SAS Nagar, Mohali and B.Pharm from Dr. Hari Singh Gour University, Sagar, M.P. She has previously held research positions at NIPER, Mohali and at Heinrich Heine University Düsseldorf, Germany. Her research focuses on the design and development of selective HDAC8 inhibitors targeting various cancers, including lung cancer and hematological malignancies, and her work has been supported by prestigious funding bodies such as CSIR, DST, DBT, and Germany’s BMBF. With over 20 peer-reviewed publications, she has made impactful contributions to drug discovery and computational medicinal chemistry. She has earned several prestigious distinctions, including the DST Women in Science and Engineering (WISE) Fellowship, the CSIR-Direct Senior Research Fellowship, and, most notably, the Best Oral Presentation Award sponsored by ACS at the International Symposium on “Innovations in Translational Therapy & Targeted Drug Delivery” organized by BITS Pilani, Hyderabad Campus. Beyond the lab, she is an avid badminton enthusiast, balancing her scientific rigor with athletic discipline.
Employment
-
Council of Scientific and Industrial Research CSIR-Direct SRF2024 - Present
-
Jadavpur University Ph.D. Scholar2022 - 2026
-
National Institute of Pharmaceutical Education and Research DBT-JRF2020 - 2021
-
Heinrich Heine University Düsseldorf BMBF-Research Fellow2019 - 2020
Education
-
Jadavpur University Ph.D.2022 - Present
-
National Institute of Pharmaceutical Education and Research Department of Pharmaceutical Analysis M.S.(Pharm.)2017 - 2019
-
Dr. Hari Singh Gour University B.Pharm2013 - 2017
Projects & Funding
Projects & funding information is unavailable.
Publications (22)
- A new class of indole-based HDAC8 inhibitors as potential anti-lung cancer agents: in silico design, synthesis, biological assessment and binding interaction analysis Save
- Read‐Across Structure‐Property Relationship‐Based Superior Prediction of Fraction Unbound in Plasma from Chemical Structure: Interpretable Models with Minimum Descriptors Save
- Exploring DPP-4: Implications in diverse diseases and structural insights for novel inhibitor design Save
- Dengue virus-host interactions: Structural and mechanistic insights for future therapeutic strategies Save
- Histone deacetylase 8 in focus: Decoding structural prerequisites for innovative epigenetic intervention beyond hydroxamates Save
- Nitrogen-containing heterocycles as important scaffold for selective and potent HDAC8 inhibition: a step towards effective, non-toxic and selective HDAC8 inhibitor discovery Save
- Unraveling HDAC11: Epigenetic orchestra in different diseases and structural insights for inhibitor design Save
- Unveiling critical structural features for effective HDAC8 inhibition: a comprehensive study using quantitative read-across structure–activity relationship (q-RASAR) and pharmacophore modeling Save
- Density functional theory (DFT) studies in HDAC-based chemotherapeutics: Current findings, case studies and future perspectives Save
- HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors Save